Equities analysts forecast that Exponent, Inc. (NASDAQ:EXPO) will announce earnings per share of $0.28 for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Exponent’s earnings. The highest EPS estimate is $0.29 and the lowest is $0.27. Exponent posted earnings per share of $0.27 in the same quarter last year, which suggests a positive year-over-year growth rate of 3.7%. The company is expected to announce its next earnings results on Wednesday, October 17th.
On average, analysts expect that Exponent will report full-year earnings of $1.28 per share for the current financial year, with EPS estimates ranging from $1.27 to $1.29. For the next year, analysts expect that the business will report earnings of $1.39 per share, with EPS estimates ranging from $1.33 to $1.44. Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Exponent.
Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, July 19th. The business services provider reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.03. The business had revenue of $95.60 million for the quarter, compared to analyst estimates of $89.42 million. Exponent had a net margin of 13.51% and a return on equity of 20.52%. The company’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.51 EPS.
A number of brokerages recently weighed in on EXPO. Berenberg Bank began coverage on shares of Exponent in a research report on Wednesday, September 12th. They set a “buy” rating for the company. ValuEngine raised shares of Exponent from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, June 5th. BidaskClub downgraded shares of Exponent from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 30th. SunTrust Banks boosted their price objective on shares of Exponent to $56.00 and gave the company a “buy” rating in a research report on Friday, July 20th. Finally, Zacks Investment Research downgraded shares of Exponent from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 20th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $34.67.
In related news, insider Richard Reiss sold 2,236 shares of the business’s stock in a transaction dated Tuesday, July 31st. The shares were sold at an average price of $49.43, for a total transaction of $110,525.48. Following the completion of the sale, the insider now owns 4,054 shares of the company’s stock, valued at approximately $200,389.22. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.80% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the business. We Are One Seven LLC grew its position in Exponent by 259.4% in the 1st quarter. We Are One Seven LLC now owns 1,434 shares of the business services provider’s stock worth $113,000 after purchasing an additional 1,035 shares during the last quarter. Strs Ohio bought a new position in Exponent in the 2nd quarter worth about $101,000. Fort L.P. bought a new position in Exponent in the 2nd quarter worth about $117,000. SG Americas Securities LLC bought a new position in Exponent in the 1st quarter worth about $205,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in Exponent by 100.0% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,952 shares of the business services provider’s stock worth $143,000 after purchasing an additional 1,476 shares during the last quarter. Hedge funds and other institutional investors own 88.84% of the company’s stock.
Shares of NASDAQ:EXPO traded down $0.85 during trading on Wednesday, reaching $53.65. 132,941 shares of the company’s stock traded hands, compared to its average volume of 193,221. Exponent has a 12 month low of $34.80 and a 12 month high of $54.58. The company has a market cap of $2.76 billion, a PE ratio of 49.81 and a beta of 0.60.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 21st. Investors of record on Friday, September 7th will be given a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend is Thursday, September 6th. Exponent’s dividend payout ratio is presently 48.60%.
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
See Also: Day Trading
Get a free copy of the Zacks research report on Exponent (EXPO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.